Two preventive tools — a maternal vaccine and a monoclonal antibody — were tied to a recent drop in RSV hospitalization rates for U.S. babies.

As winter nears and the cold and flu season sets in, the highly infectious respiratory virus RSV has again begun its spread. So far this year, the National Disease Surveillance System (NDSS ...

New phase 2b/3 trial results with MSD's experimental respiratory syncytial virus (RSV) antibody clesrovimab have fired a shot across the bows of AstraZeneca and Sanofi, currently predicting ...

GSK has claimed a new approval for its respiratory syncytial virus (RSV) vaccine Arexvy, currently locked in a battle for market share with rival shots from Pfizer and Moderna, that could lend it ...

Other common symptoms include feeling that too much mucus is collecting in the throat and excessive burping. Exactly what that cup of coffee does inside your body minute by minute (and yes ...

A new wave of talent, led by Strings, Molly Tuttle, Zach Top and others, are redefining a once-niche genre for a whole generation. By Steve Knopper Susto frontman Justin Osborne did not record ...

Several studies have previously warned over the risks of emulsifiers and colon cancer, with doctors even saying they might break down the protective layer of mucus lining the gut — allowing ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

For these reasons, it is the most widely used diagnostic test for RSV. RADTs are rapid immunoassays and are available from a variety of manufacturers in ready-made commercialized kits. With one ...

Highlights Walking pneumonia is a milder form of regular pneumonia. It can be contagious when caused by specific bacteria or ...

For his bronze, The Nawi, Bidjigal elder Uncle Steven Russell cut the hull from a specially selected stringy bark tree.

Infant hospitalization rates for respiratory syncytial virus (RSV) were 28% to 43% lower in 2024-25, the first US respiratory-virus season with broad availability of a maternal RSV vaccine (Abrysvo) ...